Streetbeat News

Earnings

DIA

SPY

UUP

U.S. manufacturing activity in March 2024 saw its fastest growth since September 2022, with the ISM Manufacturing PMI rising to 50.3. This growth exceeded expectations and led to a rebound of the dollar due to a shift in interest rate expectations. The report highlighted increases in new orders, production, and prices, indicating early recovery signs and inflationary pressures. Following the report, the S&P 500 and Dow Jones experienced slight downturns, while the U.S. dollar index rose.

Portfolio Pulse from Piero Cingari

April 01, 2024 | 3:05 pm

TM

Toyota's stock (TM) is trading lower following a report of decreased global sales in February. The decline may also be attributed to a decrease in Japan's February industrial output.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:03 pm

ZVRA

Zevra Therapeutics shares are trading lower following the announcement of worse-than-expected Q4 GAAP EPS results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:03 pm

RITM

In the last three months, 6 analysts have offered diverse ratings on Rithm Capital (NYSE:RITM), with recent actions including maintaining and raising price targets, reflecting a generally positive outlook. The average 12-month price target is $12.17, marking a 9.44% increase from the previous average of $11.12. Despite this optimism, Rithm Capital faces financial challenges, including a -21.17% decline in revenue growth and below-industry averages in net margin, ROE, and ROA, alongside a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:01 pm

MA

Mastercard (NYSE:MA) is analyzed in comparison to its competitors in the Financial Services industry, focusing on key financial metrics. Mastercard, as the second-largest payment processor globally, processed over $9 trillion in 2023. It has a PE ratio lower than the industry average, suggesting potential undervaluation, but its PB and PS ratios are higher, indicating possible overvaluation in terms of book value and sales. Mastercard's ROE, EBITDA, and gross profit are significantly above the industry average, showcasing high profitability and operational efficiency. However, its revenue growth is below the industry average, pointing to potential market share expansion challenges.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:00 pm

TSLA

The article evaluates Tesla (TSLA) against its peers in the Automobiles industry, focusing on financial metrics, market position, and growth prospects. Tesla's PE, PB, and PS ratios are significantly higher than the industry average, suggesting a premium valuation. However, its high ROE indicates strong profitability. In contrast, Tesla's EBITDA, gross profit, and revenue growth are below the industry average, raising concerns about its operational performance and growth potential.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:00 pm

MSFT

The article provides a detailed comparison of Microsoft (NASDAQ:MSFT) against its competitors in the Software industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Microsoft is highlighted for its strong performance metrics, indicating efficient operations and potential for growth. The analysis suggests Microsoft is undervalued based on its P/E and P/B ratios but may be overvalued based on its P/S ratio. Microsoft's higher EBITDA and gross profit compared to the industry average demonstrate robust profitability and cash flow generation.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:00 pm

AAPL

AMZN

META

MSFT

NVDA

TSLA

Despite downturns in Apple (AAPL) and Tesla (TSLA) shares, the S&P 500 has seen its strongest first quarter since 2019, thanks to the performance of Nvidia (NVDA), Meta Platforms (META), Microsoft (MSFT), and Amazon.com (AMZN). These 'Fab Four' have been central to the market's resilience, with investor optimism fueled by potential economic stability and interest in AI technologies. However, concerns about a possible market rally end persist, with Tesla facing competition and growth challenges, and Apple dealing with legal issues and AI positioning questions.

Portfolio Pulse from Benzinga Neuro

April 01, 2024 | 2:56 pm

DISC

Disc Medicine Inc (NASDAQ:DISC) reported Phase 2 study results for bitopertin in Erythropoietic Protoporphyria (EPP), showing significant reductions in PPIX levels and improvements in phototoxic reactions. However, the placebo group's strong performance led to non-significant results in some secondary endpoints. DISC stock plunged 58.57% to $25.80.

Portfolio Pulse from Vandana Singh

April 01, 2024 | 2:52 pm

AQB

AquaBounty Techs (NASDAQ:AQB) reported Q4 earnings with an EPS of $-2.19, missing estimates by -43.0% against an expected $-1.53. Revenue increased by $102 thousand from the same period last year. The company's past earnings performance shows a mixed trend with a notable 10.0% drop in share price following last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 2:50 pm